Evidence map›Paper›PMID 37161390›Full record

ArticleBMC medical genomics2023

A novel mutation in RNF216 gene in a Turkish case with Gordon Holmes syndrome.

Nazlı Durmaz Çelik, Ebru Erzurumluoğlu, Serkan Özben, Uğur Toprak, Göknur Yorulmaz, Sevilhan Artan, Serhat Özkan

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC medical genomics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. A novel mutation inBMJ case reports · 2023
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Nazlı Durmaz ÇelikDepartment of Neurology, Eskişehir Osmangazi University Faculty of Medicine, Eskişehir, Turkey. doktornazli@hotmail.com.
Ebru ErzurumluoğluDepartment of Medical Genetics, Faculty of Medicine, Eskişehir Osmangazi University, Eskişehir, Turkey.
Serkan ÖzbenDepartment of Neurology, University of Health Sciences, Antalya Training and Research Hospital, Antalya, Turkey.
Uğur ToprakDepartment of Radiology, Eskişehir Osmangazi University Faculty of Medicine, Eskişehir, Turkey.
Göknur YorulmazDepartment of Endocrinology, Eskişehir Osmangazi University Faculty of Medicine, Eskişehir, Turkey.
Sevilhan ArtanDepartment of Medical Genetics, Faculty of Medicine, Eskişehir Osmangazi University, Eskişehir, Turkey.
Serhat ÖzkanDepartment of Neurology, Eskişehir Osmangazi University Faculty of Medicine, Eskişehir, Turkey.
Eskişehir Osmangazi University · TRSağlık Bilimleri Üniversitesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGordon Holmes syndrome (GHS) is a rare autosomal recessive disorder characterized by hypogonadotropic hypogonadism, cognitive decline, and cerebellar ataxia. Mutations in the Ring Finger Protein 216 (RNF216) gene have been known to be associated with GHS therewithal RNF216 mutations have been detected in cases with Huntington-like disease, 4H syndrome (hypodontia, hypomyelination, ataxia and hypogonadotropic hypogonadism), and congenital hypogonadotropic hypogonadism. CASE PRESENTATION: Here we report a novel homozygous frameshift mutation in RNF216 gene c.1860_1861dupCT (p.Cys621SerfsTer56) in a patient with hypogonadotropic hypogonadism, ataxia, and cognitive decline diagnosed with GHS also co-occurrence of parkinsonism and dystonia which was not reported before.

conclusionsWe report an extremely rare case of GHS. The core features of GHS are well defined, but genotype-phenotype correlations are still limited. To understand the pathophysiology of different phenotypes, the type and localization of novel mutations need to be defined, and the effect of these different variants on clinical features needs to be determined. Further studies should explain the factors of phenotypic variability present in GHS patients with RNF216 mutations.

Indexed as

Cerebellar AtaxiaKlinefelter SyndromeAtaxiaGonadotropin-Releasing HormoneHumansHypogonadismMutationUbiquitin-Protein LigasesGonadotropin-Releasing HormoneRNF216 protein, humanUbiquitin-Protein LigasesCerebellar ataxiaGordon Holmes syndromeHypogonadotropic hypogonadismRNF216

Identifiers

PMID37161390
PMCPMC10169457
OpenAlexW4376115802

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.